A Phase II Study of Single Agent Bortezomib in Patients with Metastatic Breast Cancer: A Single Institution Experience

Author: Engel Ryan   Brown Jennifer   Von Roenn Jamie   O'Regan Ruth   Bergan Raymond   Badve Sunil   Rademaker Alfred   Gradishar William  

Publisher: Informa Healthcare

ISSN: 0735-7907

Source: Cancer Investigation, Vol.25, Iss.8, 2007-10, pp. : 733-737

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content